ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.65-0.11 (-3.99%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close2.76
Bid2.55 x 2000
Ask2.64 x 200
Day's Range2.63 - 2.80
52wk Range2.53 - 14.22
1y Target EstN/A
Market Cap231.41M
P/E Ratio (ttm)-1.59
Avg Vol (3m)1,306,506
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire11 hours ago

    ImmunoGen Completes Strategic Review to Strengthen the Organization and Drive Long-Term Growth

    ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced the completion of a strategic review of its operations.

  • Capital Cube7 days ago

    ETF’s with exposure to ImmunoGen, Inc. : September 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to ImmunoGen, Inc. Here are 5 ETF’s with the largest exposure to IMGN-US. Comparing the performance and risk of ImmunoGen, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ImmunoGen, Inc. :IMGN-US: Earnings Analysis: 2016 By the Numbers : August 31, 2016
    Capital Cubelast month

    ImmunoGen, Inc. :IMGN-US: Earnings Analysis: 2016 By the Numbers : August 31, 2016

    Categories: Yahoo Finance Get free summary analysis ImmunoGen, Inc. reports financial results for the year ended June 30, 2016. We analyze the earnings along side the following peers of ImmunoGen, Inc. – Seattle Genetics, Inc., Amgen Inc., Endocyte, Inc., Cerulean Pharma, Inc., Bristol-Myers Squibb Company, Roche Holding Ltd Genusssch., Pfizer Inc., Eli Lilly and Company, Johnson & Johnson ... Read more (Read more...)